Clinical trials sa dalawang COVID-19 vaccines isasagawa na sa China

By Dona Dominguez-Cargullo April 14, 2020 - 11:15 AM

Aprubado na sa China ang pagsasagawa ng clinical trial sa dalawang bakuna laban sa COVID-19.

Ang bakuna ay nilikha ng China National Pharmaceutical Group at ng Beijing-based na Sinovac Research and Development Company.

Sa datos ng World Health Organization (WHO) sa iba’t ibang mga bansa ay 70 bakuna ang nililikha para panlaban sa virus.

Tatlo pa lamang dito ang naisailalim na sa human trials.

Sa ngayon wala pang bakuna na ganap na inaaprubahan para panlaban sa sakit.

 

 

TAGS: China National Pharmaceutical Group, covid 19 vaccine, covid pandemic, Health, Inquirer News, News in the Philippines, Radyo Inquirer, Tagalog breaking news, tagalog news website, vaccine, World Health Organization, China National Pharmaceutical Group, covid 19 vaccine, covid pandemic, Health, Inquirer News, News in the Philippines, Radyo Inquirer, Tagalog breaking news, tagalog news website, vaccine, World Health Organization

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.